FindTrial
Sign In

Analysis of Prescription Patterns and Drug Interactions in Cancer Patient

Assessment of Medication Use Pattern and Drug-Drug Interactions among Prostate Cancer Patients. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/075129
Enrollment
150
Registered
2024-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C61- Malignant neoplasm of prostate

Interventions

Intervention1: NIL: NIL

Sponsors

NITTE( Deemed to be University), NGSM Institute of Pharmaceutical Sciences.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All the prostate cancer participants aged 18 & above. 2. Prostate cancer participants with or without comorbidities. 3. Prostate Cancer patients diagnosed with other types of cancer.

Exclusion criteria

Exclusion criteria: 1. Patients who had undergone surgical ADT. 2. Patients with incomplete data files. 3. Patients who are not willing to give consent.

Design outcomes

Primary

MeasureTime frame
The study will identify the common drug use pattern among prostate cancer patientsTimepoint: zero—

Secondary

MeasureTime frame
The study will identify the potential drug-drug interactions among prostate cancer patients.Timepoint: one year—

Countries

India

Contacts

Public ContactDr Uday Venkat Mateti

NGSM Institute Of Pharmaceutical Sciences

udayv@nitte.edu.in8152977460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026